← FDA DRUG APPROVALS

FDA ANDA · ANDA204854

MEROPENEM

Sponsor: DAEWOONG PHARM CO

APPLICATION
ANDA204854
TYPE
ANDA
ORIGINAL APPROVAL
2015-12-18
LATEST ACTION
2019-08-30
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Discontinued

Products

MEROPENEMDiscontinued
MEROPENEM 500MG/VIAL · INJECTABLE · INJECTION
MEROPENEMDiscontinued
MEROPENEM 1GM/VIAL · INJECTABLE · INJECTION

Approval history

2019-08-30Labeling · Supplement 1 · standardAP
2019-08-30Labeling · Supplement 4 · standardAP
2019-08-30Labeling · Supplement 5 · standardAP
2015-12-18UNKNOWN · Original · standardLetterAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →